| 标题 |
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Martin J van den Bent; Martin Klein; Marion Smits; Jaap C Reijneveld; Pim J French; et al 出版日期:2018 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)